查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087608

經導管栓塞和閉塞裝置市場：2026-2032年全球市場預測（按產品類型、材料、技術、適應症類型、應用和最終用戶分類）

Transcatheter Embolization & Occlusion Device Market by Product Type, Material, Technology, Indication Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，經導管栓塞和閉塞裝置市場將成長至 103.3 億美元，複合年成長率為 8.34%。

主要市場統計數據
基準年 2025 58.9億美元
預計年份：2026年 63.3億美元
預測年份 2032 103.3億美元
複合年成長率 (%) 8.34%

經導管栓塞裝置正開啟精準醫療的新時代。

經導管栓塞和閉塞裝置是現代微創治療的核心，使醫生能夠在不進行開放性手術的情況下，有目的地阻斷目標血管的血流。此類裝置包括栓塞彈簧圈、血管栓塞器、可移除球囊、顆粒、微球、液體栓塞劑以及相關的輸送系統，廣泛應用於介入性放射學、介入神經放射學、腫瘤學、創傷和周邊血管手術。

一項變革性的改變，將重塑栓塞和閉塞治療。

市場趨勢正從基於手術流程的器械選擇轉向整合的、針對特異性適應症的栓塞策略。介入團隊擴大根據血管解剖結構、血流動力學、影像可見性和再次治療風險來選擇栓塞彈簧圈、栓塞塞子、液體栓塞劑和微球。這推動了對栓塞器械可輸送性、可控釋放、滲透性以及與微導管和先進影像平台相容性的需求。

人工智慧對栓塞的累積影響

人工智慧 (AI) 正透過影像診斷、治療計畫、工作流程最佳化和證據生成等方式，逐步影響經導管栓塞和閉塞器械生態系統。 AI 驅動的分割、血管映射和影像融合技術可輔助進行病變特徵分析、營養物質識別以及複雜神經血管、腫瘤和周邊血管介入治療的治療計劃制定。在栓塞成功與否取決於精準導航和目標血管完全閉塞的情況下，這些應用尤其重要。

亞太、北美、歐洲和新興市場的關鍵區域洞察

在亞太地區，中國、日本、印度、韓國和澳洲正迅速提升其介入放射學和神經血管領域的醫療能力，這得益於龐大的患者群體、對癌症治療的投入以及微創手術的普及。北美地區由於其完善的醫院網路、專業的培訓體系、有利於手術實施的基礎設施以及FDA已通過核准的用於周邊血管、神經血管和腫瘤治療的醫療器械，仍然是介入放射學和神經血管領域應用率較高的地區。

主要集團分析涵蓋東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約。

在東協市場，由於三級介入治療服務的覆蓋範圍不斷擴大，新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的介入治療重要性日益凸顯，儘管各國在採購模式和專家資源方面存在顯著差異。在海灣合作理事會（GCC）國家，隨著醫院現代化、醫療旅遊策略的推進以及對複雜心血管、腫瘤和神經血管疾病治療的投入，介入治療的普及速度正在加快。

高附加價值栓塞和閉塞治療市場的關鍵國別洞察

美國憑藉其成熟的介入放射學、神經介入、創傷和腫瘤網路，引領醫療器材的普及應用。加拿大則受惠於先進的診療路徑，但面臨各省採購政策的差異。墨西哥和巴西是拉丁美洲的重要市場，其成長主要由私人醫院和大規模公共轉診系統推動。英國、德國、法國、義大利和西班牙憑藉其成熟的血管內介入技術，繼續支持醫療器材的普及應用，儘管歐盟的醫療設備法規 (MDR) 和各國的報銷流程正在影響市場進入。在俄羅斯，儘管採購和進口流程複雜，專業醫療機構的需求仍然強勁。

為栓塞器械行業的領導者提供的實用建議

產業領導者必須使產品開發與臨床工作流程的實際情況相符——可預測的血管阻塞、導管相容性、在彎曲解剖結構內的輸送、可控的展開以及影像可見性。實證策略不僅應關注技術上的成功，還應涵蓋再治療率、併發症減少、手術時間縮短、住院時間縮短以及為醫院帶來的經濟效益。

基於檢驗的臨床和市場證據的調查方法

本執行摘要基於二手研究，使用了經過驗證的公共和行業來源，包括監管資料庫、臨床指南、同行評審期刊、醫院採購指標、檢驗趨勢以及世界衛生組織、世界銀行、經合組織、美國食品藥品監督管理局、歐洲藥品管理局、日本藥品和醫療器材管理局、國家藥品管理局和國家衛生機構等組織提供的公共衛生資訊來源。

結論：精準閉塞療法決定下一階段的生長。

隨著微創治療在血管疾病、癌症、創傷和複雜出血性疾病等領域於醫療保健系統中的普及，經導管栓塞和閉塞器械市場預計將保持其持續的戰略重要性。臨床價值不僅取決於器械的可近性，還取決於其準確性、安全性、工作流程效率和可衡量的治療效果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 經導管栓塞及閉塞裝置市場：依產品類型分類

  • 栓塞線圈
    • 可拆卸線圈
    • 可推式線圈
  • 液態栓塞劑
    • 乙烯-乙烯醇共聚物
    • N-丁基氰基丙烯酸酯
  • 微球
  • 顆粒栓子
  • 血管栓塞

第8章 經導管栓塞及閉塞裝置市場：依材料分類

  • 金屬裝置
  • 聚合物基材料
  • 混合材料

第9章 經導管栓塞及閉塞裝置市場：依技術分類

  • 血流導栓塞術
  • 機械性閉塞
  • 微導管輸送系統

第10章：經導管栓塞及閉塞裝置市場：依適應症類型分類

  • 良性疾病
  • 惡性疾病
  • 醫療緊急狀況

第11章 經導管栓塞與閉塞裝置市場：依應用分類

  • 出血控制
  • 肝動脈栓塞術
  • 神經血管栓塞術
  • 周邊血管栓塞
  • 子宮肌瘤栓塞術

第12章 經導管栓塞和閉塞裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章 經導管栓塞及閉塞裝置市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 經導管栓塞及閉塞裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 經導管栓塞和閉塞裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Balt International
  • Boston Scientific Corporation
  • Cardiva Medical, Inc.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Guerbet SA
  • Kaneka Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Penumbra, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-03168519576B

The Transcatheter Embolization & Occlusion Device Market is projected to grow by USD 10.33 billion at a CAGR of 8.34% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.89 billion
Estimated Year [2026] USD 6.33 billion
Forecast Year [2032] USD 10.33 billion
CAGR (%) 8.34%

Transcatheter Embolization Devices Enter a Precision Care Era

Transcatheter embolization and occlusion devices are central to modern minimally invasive care, enabling physicians to intentionally block blood flow in targeted vessels without open surgery. The category includes embolic coils, vascular plugs, detachable balloons, particles, microspheres, liquid embolic agents, and related delivery systems used across interventional radiology, neurointervention, oncology, trauma, and peripheral vascular procedures.

Demand is supported by well-documented clinical need. The World Health Organization identifies cardiovascular disease as the leading cause of death globally, while cancer and stroke remain major sources of morbidity that frequently require image-guided vascular intervention. As hospitals prioritize shorter recovery times, lower procedural trauma, and higher precision, transcatheter embolization devices are increasingly positioned as essential tools for hemorrhage control, aneurysm management, tumor embolization, arteriovenous malformation treatment, and vessel occlusion before surgery or targeted therapy.

Transformative Shifts Reshaping Embolization and Occlusion Care

The market landscape is shifting from procedure-based device selection toward integrated, indication-specific embolization strategies. Interventional teams are increasingly matching embolic coils, plugs, liquid embolics, and microspheres to vessel anatomy, flow dynamics, imaging visibility, and retreatment risk. This is strengthening demand for deliverability, controlled deployment, radiopacity, and compatibility with microcatheters and advanced imaging platforms.

Regulatory and procurement dynamics are also changing. The U.S. FDA, European MDR framework, Japan PMDA, China NMPA, and other authorities continue to emphasize safety, biocompatibility, manufacturing controls, and post-market surveillance. At the same time, value-based healthcare is pushing suppliers to demonstrate reduced procedure time, fewer complications, predictable occlusion, and broad training support rather than relying on device features alone.

Cumulative Impact of Artificial Intelligence on Embolization

Artificial intelligence is beginning to influence the transcatheter embolization and occlusion device ecosystem through imaging, planning, workflow optimization, and evidence generation. AI-enabled segmentation, vessel mapping, and image fusion can support lesion characterization, feeding-vessel identification, and procedural planning in complex neurovascular, oncologic, and peripheral interventions. These applications are especially relevant where embolization success depends on precise navigation and complete target-vessel occlusion.

The near-term impact is expected to be decision-support rather than autonomous intervention. AI can help standardize case review, identify high-risk anatomy, reduce image interpretation variability, and support training simulations. For manufacturers, AI-assisted design analysis, manufacturing inspection, complaint trend detection, and real-world evidence analytics can improve quality systems while remaining subject to validated clinical, regulatory, cybersecurity, and data-governance requirements.

Key Regional Insights Across Asia-Pacific, North America, Europe, and Emerging Markets

Asia-Pacific is advancing rapidly as China, Japan, India, South Korea, and Australia expand interventional radiology and neurovascular capacity, supported by large patient populations, cancer care investment, and wider access to minimally invasive procedures. North America remains a high-adoption region due to established hospital networks, specialist training, favorable procedural infrastructure, and FDA-cleared device availability across peripheral, neurovascular, and oncology applications.

Europe benefits from strong clinical guideline adoption and advanced public health systems, although EU MDR compliance has increased documentation and evidence expectations for suppliers. Latin America shows growing use in Brazil and Mexico as tertiary hospitals broaden endovascular programs, while reimbursement variability continues to affect access. The Middle East is investing in high-acuity specialty hospitals, especially in GCC markets. Africa remains more uneven, with adoption concentrated in major urban referral centers where imaging, trained operators, and device availability are present.

Key Group Insights Covering ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining relevance as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines increase access to tertiary interventional services, although procurement models and specialist availability vary widely. GCC countries are accelerating adoption through hospital modernization, medical tourism strategies, and investment in complex cardiovascular, oncology, and neurovascular care.

The European Union remains influential through harmonized regulatory expectations, clinical evidence requirements, and broad public-sector procurement. BRICS countries offer substantial volume potential because of large disease burdens and expanding hospital infrastructure, but pricing, local registration, and reimbursement strategy are critical. G7 markets generally lead in advanced device adoption, physician training, and clinical research output. NATO economies overlap heavily with high-income health systems, supporting demand for resilient supply chains, emergency care readiness, and standardized trauma and vascular intervention capabilities.

Key Country Insights for High-Value Embolization and Occlusion Markets

The United States leads adoption through mature interventional radiology, neurointerventional, trauma, and oncology networks, while Canada benefits from advanced care pathways but faces provincial procurement differences. Mexico and Brazil are important Latin American markets, with growth centered in private hospitals and large public referral systems. The United Kingdom, Germany, France, Italy, and Spain continue to support device utilization through established endovascular expertise, while EU MDR and national reimbursement processes shape market access. Russia maintains demand in specialized centers despite procurement and import complexity.

China is scaling embolization capacity through hospital expansion and domestic device development, while India's demand is supported by rising cancer, trauma, and vascular disease treatment volumes alongside price sensitivity. Japan and South Korea are sophisticated markets with strong neurovascular and minimally invasive procedure adoption. Australia combines high clinical standards with concentrated specialist networks, making evidence, training, and supply reliability central to commercialization.

Actionable Recommendations for Embolization Device Industry Leaders

Industry leaders should align product development with clinical workflow realities: predictable occlusion, catheter compatibility, deliverability in tortuous anatomy, controlled deployment, and imaging visibility. Evidence strategies should move beyond technical success and include retreatment rates, complication reduction, procedure time, length of stay, and economic value for hospitals.

Commercial teams should prioritize physician education, simulation-based training, and indication-specific clinical support for neurovascular, peripheral, oncology, and trauma use cases. Manufacturers also need resilient supply chains, region-specific regulatory planning, robust post-market surveillance, and partnerships with imaging and AI vendors. Pricing strategies should reflect differentiated performance in high-income markets while offering scalable portfolios for cost-sensitive emerging healthcare systems.

Research Methodology Based on Verified Clinical and Market Evidence

This executive summary is grounded in secondary research from verified public and industry sources, including regulatory databases, clinical guidelines, peer-reviewed journals, hospital procurement indicators, patent activity, and public health datasets from organizations such as the WHO, World Bank, OECD, FDA, EMA, PMDA, NMPA, and national health agencies.

The methodology combines demand-side assessment of disease burden, procedure adoption, reimbursement structures, and hospital infrastructure with supply-side analysis of device portfolios, regulatory status, manufacturing capabilities, competitive positioning, and innovation trends. Findings are interpreted through cross-validation of clinical, commercial, and regulatory evidence to ensure that conclusions remain data-backed, current, and relevant for strategic decision-making.

Conclusion: Precision Occlusion Will Define the Next Growth Phase

The transcatheter embolization and occlusion device market is positioned for sustained strategic importance as healthcare systems expand minimally invasive treatment for vascular disease, cancer, trauma, and complex bleeding disorders. Clinical value is increasingly defined by precision, safety, workflow efficiency, and measurable outcomes rather than device availability alone.

Organizations that combine strong evidence generation, AI-enabled workflow integration, regulatory discipline, and physician-centered training will be best placed to compete. As regional access improves and therapeutic applications broaden, embolic coils, vascular plugs, liquid embolics, particles, and microspheres will remain critical technologies in image-guided intervention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transcatheter Embolization & Occlusion Device Market, by Product Type

  • 7.1. Embolization Coils
    • 7.1.1. Detachable Coils
    • 7.1.2. Pushable Coils
  • 7.2. Liquid Embolic Agents
    • 7.2.1. Ethylene Vinyl Alcohol Copolymer
    • 7.2.2. N-Butyl Cyanoacrylate
  • 7.3. Microspheres
  • 7.4. Particulate Embolic Agents
  • 7.5. Vascular Plugs

8. Transcatheter Embolization & Occlusion Device Market, by Material

  • 8.1. Metallic Devices
  • 8.2. Polymer-Based Materials
  • 8.3. Hybrid Materials

9. Transcatheter Embolization & Occlusion Device Market, by Technology

  • 9.1. Flow Directed Embolization
  • 9.2. Mechanical Occlusion
  • 9.3. Microcatheter Delivery Systems

10. Transcatheter Embolization & Occlusion Device Market, by Indication Type

  • 10.1. Benign Conditions
  • 10.2. Malignant Conditions
  • 10.3. Emergency Conditions

11. Transcatheter Embolization & Occlusion Device Market, by Application

  • 11.1. Hemorrhage Control
  • 11.2. Hepatic Embolization
  • 11.3. Neurovascular Embolization
  • 11.4. Peripheral Vascular Embolization
  • 11.5. Uterine Fibroid Embolization

12. Transcatheter Embolization & Occlusion Device Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Transcatheter Embolization & Occlusion Device Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Transcatheter Embolization & Occlusion Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Transcatheter Embolization & Occlusion Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Acandis GmbH
  • 17.3. AngioDynamics, Inc.
  • 17.4. AtriCure, Inc.
  • 17.5. B. Braun Melsungen AG
  • 17.6. Balt International
  • 17.7. Boston Scientific Corporation
  • 17.8. Cardiva Medical, Inc.
  • 17.9. Cook Medical LLC
  • 17.10. Edwards Lifesciences Corporation
  • 17.11. Guerbet S.A.
  • 17.12. Kaneka Corporation
  • 17.13. Medtronic plc
  • 17.14. Merit Medical Systems, Inc.
  • 17.15. MicroVention, Inc.
  • 17.16. Penumbra, Inc.
  • 17.17. Sirtex Medical Limited
  • 17.18. Stryker Corporation
  • 17.19. Teleflex Incorporated
  • 17.20. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DETACHABLE COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DETACHABLE COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DETACHABLE COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PUSHABLE COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PUSHABLE COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PUSHABLE COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIQUID EMBOLIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIQUID EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIQUID EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ETHYLENE VINYL ALCOHOL COPOLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ETHYLENE VINYL ALCOHOL COPOLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ETHYLENE VINYL ALCOHOL COPOLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL N-BUTYL CYANOACRYLATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL N-BUTYL CYANOACRYLATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL N-BUTYL CYANOACRYLATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROSPHERES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MICROSPHERES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PARTICULATE EMBOLIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARTICULATE EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARTICULATE EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR PLUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR PLUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR PLUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL METALLIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL METALLIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL METALLIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYMER-BASED MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYMER-BASED MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYMER-BASED MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HYBRID MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HYBRID MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HYBRID MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLOW DIRECTED EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FLOW DIRECTED EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLOW DIRECTED EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MECHANICAL OCCLUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MECHANICAL OCCLUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MECHANICAL OCCLUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROCATHETER DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MICROCATHETER DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROCATHETER DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BENIGN CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BENIGN CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BENIGN CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MALIGNANT CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MALIGNANT CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MALIGNANT CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMERGENCY CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EMERGENCY CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EMERGENCY CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEMORRHAGE CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEMORRHAGE CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEMORRHAGE CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEPATIC EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEPATIC EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEPATIC EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROVASCULAR EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROVASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UTERINE FIBROID EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UTERINE FIBROID EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL UTERINE FIBROID EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 154. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 181. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 209. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 210. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 218. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 219. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 220. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 227. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 228. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 245. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 254. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 255. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 263. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 264. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 265. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 272. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 273. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 281. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 282. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 283. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2018-2032 (USD MILLION)
  • TABLE 299. INDIA TRANSCATHETER EMBOLIZATIO